Searched for
NEUREN PHARMACEUTICALS LIMITED
Australian shares rebound after five-day slump; S&P/ASX 200 gains 1.09% led by energy, technology, and health care stocksThe Australian share market saw a modest recovery on Tuesday, March 10, with the S&P/ASX 200 index rising 1.09% to 8,692.60. Despite a rece...
ASX closes lower with heavy losses in technology and healthcare; energy emerges as rare bright spotAustralian shares experienced a significant downturn on Tuesday, March 3. The S&P/ASX 200 index saw a substantial drop, pulled down by heav...
S&P/ASX 200 edges lower as Australian shares lose momentum after two days of rally; Gold stocks drop over 4 per cent, check top gainers-losers and how different sectors performedAustralian shares experienced a downturn on Thursday, February 5, 2026. The S&P/ASX 200 index saw a decline, primarily driven by losses in ...
S&P/ASX 200 ends day in positive: Australian stocks rebound as miners gain, RBA hikes cash rate as expected; check top gainers-losers and how different sectors performedAustralian shares saw a strong rebound on Tuesday, recovering from a three-week low. The S&P/ASX 200 index gained significantly, boosted by...
Australian shares end week on positive note as banking stocks push equities to near 3-month high; check ASX 200 top gainers, losers and top performing sectorsAustralian shares concluded the week on a positive note, with the S&P/ASX 200 reaching its highest close since late October 2025. The bench...
Australian Stock Market ends week on a high: ASX 200 sees gain, other key indexes also witness upward trend; check top gainers and losersThe Australian stock market (ASX) closed higher on Friday, December 12, 2025. The S&P/ASX 200 index saw a rise of 1.23%, reaching 8,697.30 ...
ASX closes day on positive side: Light & Wonder, Amcor among top gainers, James Hardie tops losers list; check top 5 gainers and losersThe ASX finished Thursday, November 6, 2025, on a high note. The S&P/ASX 200 index saw a gain of 0.30%. Major indices like the S&P/ASX 20, ...